There Are No Useful CYP3A Probes that Quantitatively Predict the In Vivo Kinetics of Other CYP3A Substrates and No Expectation that One Will Be Found

Table 2.

Spearman Rank Correlations for Relationships Between Five Clearance Values*

CLSMidazolam CLOMidazolam CLSTriazolam CLOTriazolam
All correlation coefficients (r) were statistically significant at p<0.001 except where noted otherwise. CL O , oral clearance; CL S , systemic clearance 1 Not significant, p=0.11. 2 p=0.004. 3 p=0.028. *Spearman rank correlations derived from data presented in (2).
CLO Alprazolam 0.361 0.602 0.70 0.66
CLS Midazolam 0.70 0.66 0.483
CLO Midazolam 0.77 0.68
CLS Triazolam 0.71

This Article

  1. MI April 2005 vol. 5 no. 2 79-83